GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Procter & Gamble Health Ltd

P&G Health Q2 FY27 Net Profit Rises to ₹11,151 Lakhs; Revenue ₹38,249 Lakhs

RESULTS ▲ Positive Development LOW RISK
📅 Filed on BSE: 02 Nov 2026, 02:49 PM IST  ·  BSE ID: 89505e9e-ee2e-4403-9a9d-f34b26169624
View Original BSE Filing (PDF)
💡
In Simple Terms
Procter & Gamble Health reported an increase in net profit to ₹11,151 Lakhs and revenue to ₹38,249 Lakhs for the quarter.
🤖 AI Summary
  • Net Profit for Q2 FY27 rose to ₹11,151 Lakhs, compared to ₹9,615 Lakhs in Q1 FY27.
  • Revenue from Operations for Q2 FY27 reached ₹38,249 Lakhs, up from ₹36,371 Lakhs in Q1 FY27.
  • Profit before exceptional items and tax for the quarter was ₹15,005 Lakhs.
  • Basic and Diluted Earnings Per Share (after exceptional items) for Q2 FY27 stood at ₹67.18.
  • The Board of Directors approved the unaudited financial results on November 2, 2026.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Revenue from Operations (Q2 FY27)
38249 Lakhs
17.72%
Net Profit for the Period (Q2 FY27)
11151 Lakhs
17.05%
Basic and Diluted EPS (Q2 FY27)
67.18 ₹
26.04%
Total Assets (as at Sep 30, 2026)
101459 Lakhs
Total Equity (as at Sep 30, 2026)
65805 Lakhs
🏢 How This Affects the Company
📈
Business Impact
Revenue from operations increased sequentially from the prior quarter, indicating continued sales activity in its Pharmaceuticals segment.
💰
Financial Impact
Net profit increased quarter-on-quarter, reaching ₹11,151 Lakhs, and total assets expanded to ₹1,01,459 Lakhs as of September 30, 2026.
⚙️
Operational Impact
The company continues its operations within the Pharmaceuticals segment, as identified as its single primary reportable segment.
👥 What This Means For Shareholders
✅
Action Required
No action required from shareholders based on this financial results filing.
👤
Who Is Affected
All shareholders are affected as the company's financial performance, indicated by net profit of ₹11,151 Lakhs and total income of ₹38,638 Lakhs, directly impacts the company's underlying value.
🔍
Management Signal
The Board's approval and disclosure of the Q2 FY27 unaudited financial results signals routine financial transparency and adherence to regulatory requirements.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Q3 FY27 financial results — review revenue and net profit trends.
Any further disclosures regarding operational efficiency or market strategies.
Updates on the company's financial position, particularly cash and liabilities.
LOW RISK The filing reports routine quarterly financial results with no specific new risks identified.
💡 Investor Takeaway
Procter & Gamble Health Ltd. reported Q2 FY27 Net Profit of ₹11,151 Lakhs, increasing from ₹9,615 Lakhs in the previous quarter. Revenue from Operations stood at ₹38,249 Lakhs, up from ₹36,371 Lakhs. These unaudited results were approved by the Board on November 2, 2026.
⚖️ Strengths & Concerns

✅ Positives

  • Net Profit for Q2 FY27 grew to ₹11,151 Lakhs from ₹9,615 Lakhs in the preceding Q1 FY27.
  • Revenue from Operations increased to ₹38,249 Lakhs in Q2 FY27, up from ₹36,371 Lakhs in Q1 FY27.

⚠️ Concerns

  • Total expenses for Q2 FY27 were ₹23,633 Lakhs, indicating ongoing operational costs.
  • Deferred tax assets (Net) decreased from ₹3,070 Lakhs as at March 31, 2026, to ₹2,633 Lakhs as at September 30, 2026.
📅 Company Track Record
Procter & Gamble Health Ltd. reported Q1 FY27 net profit of ₹9,615 Lakhs, aided by a ₹3,180 Lakhs property sale gain. Q1 FY27 sales were ₹35,637 Lakhs. The current Q2 FY27 results show a net profit of ₹11,151 Lakhs and revenue of ₹38,249 Lakhs.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What was Procter & Gamble Health's net profit in Q2 FY27?
Procter & Gamble Health Ltd. reported a Net Profit of ₹11,151 Lakhs for the quarter ended September 30, 2026 (Q2 FY27).
What was the revenue from operations for Procter & Gamble Health in Q2 FY27?
The Revenue from Operations for Procter & Gamble Health Ltd. in Q2 FY27 was ₹38,249 Lakhs.
How much was the basic and diluted EPS for Procter & Gamble Health in Q2 FY27?
The Basic and Diluted Earnings Per Share (after exceptional items) for Procter & Gamble Health Ltd. in Q2 FY27 was ₹67.18.
What were the total assets of Procter & Gamble Health as of September 30, 2026?
As of September 30, 2026, Procter & Gamble Health Ltd.'s total assets stood at ₹1,01,459 Lakhs.
When were Procter & Gamble Health's Q2 FY27 results approved?
The Board of Directors of Procter & Gamble Health Ltd. approved the unaudited financial results for Q2 FY27 on November 2, 2026.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again — explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.